Nevertheless, a recent study demonstrated that COVID-19 vaccination can rapidly prime CD4 T spike-specific cells independently of antiviral therapy (ART), leading to a transient increase in CD4 count and a small drop in HIV viral load [12]. The gene discussed is CD4; the disease is COVID-19.